Suppr超能文献

新型吡哆醇 - 三唑类抗阿尔茨海默病药物的设计、合成、生物学评价及分子对接研究

Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine-triazoles as anti-Alzheimer's agents.

作者信息

Pal Tiyas, Bhimaneni Saipriyanka, Sharma Abha, Flora S J S

机构信息

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Raebareli India

Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research Raebareli India

出版信息

RSC Adv. 2020 Jul 9;10(44):26006-26021. doi: 10.1039/d0ra04942e.

Abstract

A series of multi-target natural product-pyridoxine based derivatives were designed, synthesized, characterized and evaluated as anti-Alzheimer agents. testing revealed the multi-functional properties of compounds such as inhibition of acetylcholinesterase (AChE), antioxidant and metal chelation. Among the series, 5i derivative was found most potent AChE inhibitor, possess antioxidant potential and chelating metal ions. Further binding interaction of 5i with AChE was studied using molecular docking, showed interaction with both PAS and CAS site of AChE. predictions were also performed to predict toxicity and ADME properties of the molecule 5i and found within drug likeness range. Therefore, 5i could be a promising multi-functional compound that can be used for further development of novel drug for Alzheimer disease.

摘要

设计、合成、表征并评估了一系列基于多靶点天然产物-吡哆醇的衍生物作为抗阿尔茨海默病药物。测试揭示了这些化合物的多功能特性,如抑制乙酰胆碱酯酶(AChE)、抗氧化和金属螯合作用。在该系列中,发现5i衍生物是最有效的AChE抑制剂,具有抗氧化潜力并能螯合金属离子。使用分子对接研究了5i与AChE的进一步结合相互作用,结果表明其与AChE的PAS和CAS位点均有相互作用。还对分子5i的毒性和ADME性质进行了预测,发现其在药物相似性范围内。因此,5i可能是一种有前景的多功能化合物,可用于进一步开发治疗阿尔茨海默病的新型药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d1b/9055346/b0bda7ae869a/d0ra04942e-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验